Global health research project to decrease the cost of vaccines

A low-cost manufacturing platform has the potential to save millions of lives worldwide.

One of the most significant barriers to global immunisation is the cost of vaccine production. 

Prof Tarit K. Mukhopadhyay, UCL Department of Biochemical Engineering, is leading an innovative research project to produce life-saving vaccines for less than 15 cents a dose.

The ULTRA (Ultra-low cost, Transferable Automated Platform for Vaccine Manufacture) project aims to create a generic, low-cost manufacturing platform that standardises the development and production of new recombinant protein vaccines. 

Tarit received £14 million funding from the Gates Foundation. The team at UCL will be working with partners Prof J. Christopher Love from MIT and Prof David Volkin from the University of Kansas.
 

Related links:

• Ultra Scale-Down Approach
• Prof Mukhopadhyay